Why cholesterol ester transfer protein (CETP) inhibitors have and will likely continue to fail in trials undertaken to increase blood concentrations of HDL-cholesterol and reduce cardiovascular events
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.